ClinVar Miner

Submissions for variant NM_000996.4(RPL35A):c.125A>G (p.Tyr42Cys)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV002308738 SCV002600916 likely pathogenic not provided 2022-05-10 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25424902, 32241839, 29146883)
Ambry Genetics RCV002427776 SCV002680495 likely pathogenic Diamond-Blackfan anemia 2015-04-23 criteria provided, single submitter clinical testing The p.Y42C variant (also known as c.125A>G), located in coding exon 2 of the RPL35a gene, results from an A to G substitution at nucleotide position 125. The tyrosine at codon 42 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant was identified in two unrelated individuals with Diamond Blackfan anemia; the variant was not carried by their unaffected parents and considered to be likely de novo in the two probands (Wang R et al. Br J Haematol. 2015;168(6):854-64). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Labcorp Genetics (formerly Invitae), Labcorp RCV003514552 SCV004292263 uncertain significance Diamond-Blackfan anemia 5 2023-02-11 criteria provided, single submitter clinical testing This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 42 of the RPL35A protein (p.Tyr42Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with RPL35A-related condition (PMID: 25424902, 29146883). ClinVar contains an entry for this variant (Variation ID: 1723464). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
CeGaT Center for Human Genetics Tuebingen RCV002308738 SCV004704303 likely pathogenic not provided 2024-01-01 criteria provided, single submitter clinical testing RPL35A: PM2, PM6, PS4:Moderate, PP3

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.